BIGG

Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians

Qaseem, A; Hopkins, RH Jr; Sweet, D. E; Starkey, M; Shekelle, P.

Ann. intern. med; 159 (12), 2013

DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...

Insuficiencia Renal Crónica/diagnóstico, Insuficiencia Renal Crónica/tratamiento farmacológico, Progresión de la Enfermedad, Triaje, Antagonistas de Receptores de Angiotensina/uso terapéutico, Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico, Antihipertensivos/uso terapéutico, Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico, Hipolipemiantes/uso terapéutico, Gemfibrozilo/uso terapéutico, Enfermedades Asintomáticas, Quimioterapia Combinada, Enfoque GRADE

Texto completo

Chronic kidney disease (stage 4 or 5): management of hyperphosphataemia

This guideline covers managing hyperphosphataemia in children, young people and adults with stage 4 or 5 chronic kidney disease. It makes recommendations on dietary management and phosphate binders, to reduce variation in care and the risk of hyperparathyroidism for people with chronic kidney disease....